Quanta aims to improve the lives of dialysis patients by providing advanced haemodialysis solutions for use in a range of care settings. SC+ is designed with you in mind and provides flexibility for patients, carers and providers.
Our mission at quanta is to improve the lives of patients by using innovative design and cutting edge technology to provide affordable solutions in renal care.
Our mission at quanta is to improve the lives of patients by using innovative design and cutting edge technology to provide affordable solutions in renal care.
Location: United Kingdom, England, Stratford-on-Avon
Employees: 51-200
Phone: +44 1789 400043
Total raised: $447.03M
Founded date: 2008
Investors 1
| Date | Name | Website |
| - | Wellington... | wellington... |
Funding Rounds 6
| Date | Series | Amount | Investors |
| 18.11.2024 | Series E | $60M | - |
| 25.06.2021 | Series D | $245M | b-to-v Par... |
| 31.07.2019 | Series C | $48M | - |
| 29.07.2019 | Series C | $48M | - |
| 18.08.2015 | - | $2.9M | - |
| 03.11.2014 | - | $43.13M | - |
Mentions in press and media 15
| Date | Title | Description |
| 18.11.2024 | Quanta Dialysis Technologies Closes Over $60M Series E Funding | Quanta Dialysis Technologies, a Warwick, UK-based company dedicated to transforming kidney care through its Quanta™ Dialysis System, raised over $60M in Series E funding. The round was led by Novo Holdings, Glenview Capital and b2venture, w... |
| 18.11.2024 | Quanta Dialysis Technologies: Kidney Care Company Closes Over $60 Million (Series E Preferred Stock) | Quanta Dialysis Technologies, a leader in transforming kidney care through its Quanta Dialysis System, announced it has closed its oversubscribed Series E Preferred Stock financing round, raising more than $60 million of additional capital.... |
| 25.06.2021 | Quanta Raises $245M In Series D Funding | Quanta Dialysis Technologies Ltd, an Alcester, England, and Beverly, MA-based medical technology company focusing dialysis care, raised $245m in Series D funding. The round was led by Glenview Capital and co-led by Novo Holdings, with parti... |
| 23.06.2021 | Portable dialysis machine maker Quanta lands $245M to boost U.S. reach Are Real-time Gene Therapy Results Possible? | After starting off 2021 with an FDA clearance for its portable dialysis machine, Quanta Dialysis Technologies has now raised a massive $245 million venture capital round to help roll out its next-generation device to both acute and chronic ... |
| 23.06.2021 | Portable dialysis machine maker Quanta lands $245M to boost U.S. reach | After starting off 2021 with an FDA clearance for its portable dialysis machine, Quanta Dialysis Technologies has now raised a massive $245 million venture capital round to help roll out its next-generation device to both acute and chronic ... |
| 23.06.2021 | Quanta Raises $245 Million to Accelerate Commercialization of its SC+ Portable Hemodialysis System | Quanta announced that it has raised $245 million in an oversubscribed and upsized Series D round, the largest private funding round for a dialysis device company in history. |
| 29.07.2019 | Quanta Raises $48M in Series C Funding | Quanta Dialysis Technologies Ltd, an Alcester, Warwickshire, UK-based medical technology company developing a personal haemodialysis system (SC+) for patient use in the clinic and the home, raised £38m ($48m) in a first closing of its Serie... |
| 29.07.2019 | Quanta raises $48 million in Series C funding round | Quanta Dialysis Technologies today announces that it has successfully raised £38 million ($48 million) in a first closing of its Series C funding round. The round was led by a Swiss private family office in combination with btov Partners an... |
| 29.07.2019 | Quanta Dialysis Technologies raises $48m | Quanta Dialysis Technologies (Alcester, U.K.) said today that it has closed on a £38 million ($48 million) Series C funding round. The money will support the British commercial launch of the company’s SC+ personal hemodialysis system as wel... |
| 29.07.2019 | British medtech company Quanta raises $48 million in Series C funding as it gears up for commercial launch | UK-based medical technology company Quanta, which develops compact but advanced haemodialysis systems – under the brand ‘SC+’ – for use in the home and in clinics, has secured $48 million in Series C funding. The financing round was led by ... |
Show more